Guidance for industry : S1C(R2) dose selection for carcinogenicity studies.
| Other author | Center for Drug Evaluation and Research (U.S.) |
| Other author | Center for Biologics Evaluation and Research (U.S.) |
| Other author | International Conference on Harmonisation. |
| Format | Electronic |
| Publication Info | Silver Spring, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research ; [Rockville, MD] : Center for Biologics Evaluation and Research, [2008] |
| Description | i, 10 p. : digital, PDF file |
| Supplemental Content | https://purl.fdlp.gov/GPO/LPS111012 |
| Subjects |
| Portion of title | Dose selection for carcinogenicity studies |
| General note | Title from PDF title page (viewed on Apr. 6, 2009). |
| General note | "ICH." |
| General note | "Revision 1." |
| General note | "September 2008." |
| General note | GPO Cataloging Record Distribution Program (CRDP). |
| Technical details | Mode of access: Internet at the FDA CDER Web site. Address as of 4/06/09: http://www.fda.gov/cder/guidance/8349fnl.pdf ; current access is available via PURL. |
| GPO item number | 0499-T-02 (online) |
| Govt. docs number | HE 20.4802:C 17 |